Mila – Quebec Artificial Intelligence Institute announced today that AbCellera, a Vancouver-based technology company that helps to discover new antibody-based medicines and bring them to patients faster, has joined its community of industrial partners.
Read MoreVentus Therapeutics, Inc., a biopharmaceutical company utilizing structural biology and a proprietary computational chemistry platform to identify and develop small molecule therapeutics across a broad range of diseases, announced today the opening of a new office and lab facility in Waltham, Massachusetts as the first phase of its planned global expansion.
Read More
